To assess the predictive value of GADD45B for an adjuvant chemotherapy benefit, we compared the PFS of stage II CRC patients who underwent adjuvant chemotherapy or not in the subgroup after being stratified by GADD45B expression. Here, GADD45B is linked to colorectal carcinoma.